ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
President Cam Gallagher sold $285K of Zentalis Pharmaceuticals, Inc.
Sold$284,683
$22.77Price
12,500Shares
−3%Stake
What ZNTL did after the filing
- The stock from Tue, Nov 15 close, $22.94
- −19.8%
- S&P 500, same days
- −3.3%
Measured over 30 trading days, to the Dec 29 close.
Traded Tue, Nov 15. Filed Tue, Nov 15, 2:50 PM ET, during the session. Returns use the Nov 15 close and the Dec 29 close. Not investment advice.